Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 5
2006 7
2007 7
2008 15
2009 16
2010 5
2011 9
2012 5
2013 2
2014 8
2015 4
2016 6
2017 2
2018 4
2019 3
2020 5
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 27776398

101 results
Results by year
Filters applied: . Clear all
Page 1
The Relief Effects of Ramelteon on Refractory Chronic Migraine: A Case Report.
Hou YC, Lai CH. Hou YC, et al. Clin Psychopharmacol Neurosci. 2016 Nov 30;14(4):405-406. doi: 10.9758/cpn.2016.14.4.405. Clin Psychopharmacol Neurosci. 2016. PMID: 27776398 Free PMC article.
Ramelteon for the treatment of insomnia.
Borja NL, Daniel KL. Borja NL, et al. Clin Ther. 2006 Oct;28(10):1540-55. doi: 10.1016/j.clinthera.2006.10.016. Clin Ther. 2006. PMID: 17157111 Review.
Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
Mini L, Wang-Weigand S, Zhang J. Mini L, et al. Clin Ther. 2008 Jul;30(7):1316-23. doi: 10.1016/s0149-2918(08)80056-2. Clin Ther. 2008. PMID: 18691991
A Cluster Headache Responsive to Ramelteon, a Selective Melatonin MT1/MT2 Receptor Agonist.
Imai N. Imai N. Intern Med. 2016;55(17):2483-5. doi: 10.2169/internalmedicine.55.6621. Epub 2016 Sep 1. Intern Med. 2016. PMID: 27580554 Free article.
Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
Wang-Weigand S, Watissée M, Roth T. Wang-Weigand S, et al. Sleep Med. 2011 Oct;12(9):920-3. doi: 10.1016/j.sleep.2011.06.008. Epub 2011 Sep 16. Sleep Med. 2011. PMID: 21925941 Clinical Trial.
Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
Spadoni G, Bedini A, Lucarini S, Mor M, Rivara S. Spadoni G, et al. Expert Opin Drug Metab Toxicol. 2015 Jul;11(7):1145-56. doi: 10.1517/17425255.2015.1045487. Epub 2015 May 8. Expert Opin Drug Metab Toxicol. 2015. PMID: 25956235 Review.
Pharmacotherapy of insomnia with ramelteon: safety, efficacy and clinical applications.
Pandi-Perumal SR, Spence DW, Verster JC, Srinivasan V, Brown GM, Cardinali DP, Hardeland R. Pandi-Perumal SR, et al. J Cent Nerv Syst Dis. 2011 Apr 12;3:51-65. doi: 10.4137/JCNSD.S1611. Print 2011. J Cent Nerv Syst Dis. 2011. PMID: 23861638 Free PMC article.
Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J, Cohen DA, Sharpley AL. McCleery J, et al. Cochrane Database Syst Rev. 2014 Mar 21;(3):CD009178. doi: 10.1002/14651858.CD009178.pub2. Cochrane Database Syst Rev. 2014. PMID: 24659320 Updated. Review.
Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.
Wang-Weigand S, McCue M, Ogrinc F, Mini L. Wang-Weigand S, et al. Curr Med Res Opin. 2009 May;25(5):1209-13. doi: 10.1185/03007990902858527. Curr Med Res Opin. 2009. PMID: 19327100
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.
Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, Roth T. Zammit G, et al. J Clin Sleep Med. 2007 Aug 15;3(5):495-504. J Clin Sleep Med. 2007. PMID: 17803013 Free PMC article. Clinical Trial.
101 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback